ClinicalTrials.gg
Not yet recruitingNCT07732595Updated Jul 30, 2026

Combined and Aquatic Exercise in Chronic Low Back Pain

An interventional study of Aquatic-exercise Program and Land-based Exercise Program in Chronic Low-back Pain (cLBP), sponsored by University of Beira Interior. Not yet recruiting at 1 site in Portugal. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-30.

Sponsored by University of Beira Interior · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this randomized clinical trial is to evaluate the effects of a combined aquatic- and land-based exercise program, as well as an aquatic-exercise program, compared with a control group receiving home-based exercise, on pain, disability, and functional capacity in adults with CLBP. Secondary objectives include examining the effects on fear of movement, anxiety and depression, quadriceps and hand-grip strength, and lumbar mobility. The main question it aims to answer is: "Which type of exercise program is most effective at improving pain, disability, functional capacity, fear of movement, anxiety and depression, quadriceps and hand-grip strength, and lumbar mobility in adults with chronic low back pain?".

Participants will perform an aquatic-based exercise program (aquatic group), a combined aquatic and land-based exercise program (aquatic and land group), or a land-based exercise program (home group).

Researchers will compare groups to find any differences in pain, disability, functional capacity, kinesiophobia, anxiety and depression, quadriceps and hand-grip strength, and lumbar mobility.

02

Conditions studied

  • Chronic Low-back Pain (cLBP)

Keywords

  • Back Pain
  • Disability
  • Exercise
  • Aquatic Therapy
  • Physical Capacity
03

In context

Back Pain

729 studies on the registry are indexed under Back Pain; 110 are open to participants now.

This study's planned enrollment of 90 is above the median of 70 across 594 interventional studies indexed under Back Pain.

Browse Back Pain studies →

Lead sponsor

University of Beira Interior is the lead sponsor of 15 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • all genders;
  • aged over 18 years;
  • Chronic Low Back Pain lasting three months or longer and with an intensity of 3 or higher on the Visual Analogue Scale at rest.

Exclusion criteria

Exclusion Criteria:

  • Individuals who refuse to participate or do not provide ;
  • Pain radiating to the lower limb;
  • Recent pregnancy or childbirth (less than 8 weeks ago);
  • Ongoing physical therapy treatments;
  • Severe rheumatological, neurological, neoplastic, cardiovascular diseases or other conditions that could prevent full participation in the intervention;
  • History of spinal surgery;
  • Inflammatory, infectious, or malignant spinal diseases;
  • Psychiatric disorders that may affect adherence and symptom assessment.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Aquatic and Land Group

    This arm will include 24 exercise sessions (three non-consecutive sessions per week), conducted over an 8-week period. 16 sessions of the aquatic-exercise program and 8 sessions of the land-based exercise program.

    Other: Aquatic-exercise Program · Other: Land-based Exercise Program

  • Experimental
    Aquatic Group

    This arm will comprise 24 sessions of the aquatic-exercise program (three non-consecutive sessions per week), conducted over an 8-week period.

    Other: Aquatic-exercise Program

  • Active comparator
    Home Group

    This arm will include 24 sessions of the home-based exercise program (three non-consecutive sessions per week) over an 8-week period.

    Other: Home-based Exercise Program

Interventions

  • OtherAquatic-exercise Program

    This intervention will consist of an aquatic-exercise program, performed in shallow water (120-150 cm deep) at a temperature of 32-34 °C, and supervised by a physiotherapist with over two years of experience in aquatic-based exercise and Ai Chi method. The aquatic-exercise sessions, will consist of a 5-minute warm-up phase, a 30-40-minute training phase, and a 10-15-minute relaxation/cool-down phase, adapted from Ai Chi exercise positions. The Ai Chi method consists of 19 katas (movements) that incorporate deep breathing, coordinated upper and lower limb actions, trunk control, and slow, continuous motion. In this study, only 10 of these 19 katas will be included in the aquatic-exercise protocol.

  • OtherLand-based Exercise Program

    This program will include specific land-based exercises, supervised by a physiotherapist with more than two years of experience in therapeutic exercise. The land-based exercise program, will be divided into three components: core stability exercises (15-20 minutes), trunk and lower limb stretching exercises (10-15 minutes), and relaxation/coordination exercises adapted from the Ai Chi method (10-15 minutes).

  • OtherHome-based Exercise Program

    This exercise program will consist of a home-based exercise program. Each session will last 20-30 minutes and will be performed individually at home without professional supervision. The home-based exercise program will include core stability exercises that progress from the supine to the quadruped position. It will mirror the land-based exercise program and is adapted from a previous unsupervised home-based protocol.

06

What researchers measure

Primary outcomes

  1. Visual Analogue Scale

    Pain intensity will be assessed with the Visual Analogue Scale (Minimum: 0; Maximum 10). Higher values correspond to worse outcome.

    Time frame: One measurement will be assessed at baseline and one at each follow-up (8 and 12 weeks).

  2. Oswestry Disability Index - version 2.0

    Disability due to low back pain will be assessed with the Oswestry Disability Index (Minimum: 0; Maximum 100). Higher values correspond to worse outcome.

    Time frame: One measurement will be assessed at baseline and one at each follow-up (8 and 12 weeks).

  3. Short Physical Performance Battery

    Lower-limb functional capacity (balance, gait speed, chair stands) will be assessed with the Short Physical Performance Battery, a simple tool that includes the four-meter gait speed test, the five-repetition sit-to-stand test and a balance test, and gives a total score based on the performance in each of those tests. Each component is scored (0-4), yielding a composite score (0-12), with higher scores indicating better performance.

    Time frame: One measurement will be assessed at baseline and one at each follow-up (8 and 12 weeks).

Secondary outcomes

  1. Tampa Scale of Kinesiophobia-13

    Fear of movement will be assessed with the Tampa Scale of Kinesiophobia-13 (Minimum: 13; Maximum 52). Higher values correspond to worse outcome.

    Time frame: One measurement will be assessed at baseline and one at each follow-up (8 and 12 weeks).

  2. Hospital Anxiety and Depression Scale

    Anxiety and depression will be assessed with the Hospital Anxiety and Depression Scale (Minimum: 0; Maximum 21). Higher values correspond to worse outcome.

    Time frame: One measurement will be assessed at baseline and one at each follow-up (8 and 12 weeks).

  3. Fixed Handheld Dynamometry for Assessing Quadriceps Strength

    Quadriceps muscle (both sides) maximum voluntary isometric contraction will be assessed with Fixed Handheld Dynamometry with participants seated and the knee positioned at approximately 90° of flexion.

    Time frame: Three measurements will be assessed at baseline and three at each follow-up (8 and 12 weeks).

  4. Hand-Grip Dynamometry

    Maximum isometric strength of the hand and forearm muscles (both sides) will be assessed with Hand-Grip Dynamometry with participants seated with the elbow flexed at 90° and the forearm in a neutral position.

    Time frame: Three measurements will be assessed at baseline and three at each follow-up (8 and 12 weeks).

  5. Modified-Modified Schober Test

    Lumbar spine range of motion will be assessed with the Modified-Modified Schober Test.

    Time frame: Three measurements will be assessed at baseline and three at each follow-up (8 and 12 weeks).

07

Study locations

1 site
  • University of Beira Interior
    Covilha, Castelo Branco District 6201-001, Portugal
    • Joana Borges, MSc · Contactjoanaccborges24@hotmail.com · +351964928447
    • Joana Borges, MSc · Principal investigator
    • Henrique Neiva, PhD · Principal investigator
    • Diogo Monteiro, PhD · Principal investigator
    • Fernanda M. Silva, PhD · Sub investigator
    • Tiago Pastilha, MSc · Sub investigator
    • Pedro Duarte-Mendes, PhD · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Feb 2027, 5 months later.

Of 259 non-industry interventional studies with no phase under Back Pain, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 33. This study's planned 5 months is below that.

Counting every sponsor, half of 294 studies reached it within 13 months; a quarter within 5 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 23, 2026
First posted
Jul 29, 2026
StartEst.
Sep 2026
Primary completionEst.
Feb 2027
CompletionEst.
May 2027
Last update
Jul 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07732595
Lead sponsor
University of Beira Interior
Collaborators
Instituto Politécnico de Leiria, Instituto Politécnico de Castelo Branco
Responsible party
Joana Catarina Carvalho Borges (Principal Investigator, University of Beira Interior) — Principal investigator
First posted
Jul 29, 2026
Start date
Sep 2026 (estimated)
Primary completion
Feb 2027 (estimated)
Completion
May 2027 (estimated)
Last update
Jul 30, 2026

Study contacts

Joana Borges, MSc
Contact
joanaccborges24@hotmail.com
+351964928447
Pedro Duarte-Mendes, PhD
study director · Instituto Politécnico de Castelo Branco
Henrique Neiva, PhD
study director · University of Beira Interior
Diogo Monteiro, PhD
study director · Instituto Politécnico de Leiria

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion